BrightSpring Health Services (NASDAQ:BTSG) Receives Buy Rating from BTIG Research

BrightSpring Health Services (NASDAQ:BTSG)‘s stock had its “buy” rating reaffirmed by equities researchers at BTIG Research in a note issued to investors on Thursday,Benzinga reports. They currently have a $55.00 price objective on the stock. BTIG Research’s price objective would indicate a potential upside of 27.70% from the stock’s previous close.

BTSG has been the subject of a number of other research reports. TD Cowen reaffirmed a “buy” rating on shares of BrightSpring Health Services in a research report on Monday, March 2nd. Morgan Stanley boosted their target price on BrightSpring Health Services from $40.00 to $48.00 and gave the company an “overweight” rating in a research report on Wednesday, March 4th. Leerink Partners restated an “outperform” rating and set a $49.00 price target on shares of BrightSpring Health Services in a research note on Wednesday. UBS Group raised their price target on BrightSpring Health Services from $53.00 to $55.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of BrightSpring Health Services in a research note on Monday, December 29th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $45.50.

BrightSpring Health Services Trading Up 2.3%

NASDAQ BTSG opened at $43.07 on Thursday. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.57 and a quick ratio of 1.12. The stock has a market capitalization of $8.34 billion, a P/E ratio of 48.94, a PEG ratio of 0.55 and a beta of 2.31. The firm’s 50-day moving average is $39.86 and its two-hundred day moving average is $34.92. BrightSpring Health Services has a 12 month low of $15.48 and a 12 month high of $44.87.

BrightSpring Health Services (NASDAQ:BTSG) last announced its quarterly earnings results on Friday, February 27th. The company reported $0.33 earnings per share for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.01). The company had revenue of $3.55 billion for the quarter, compared to analyst estimates of $3.38 billion. BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. BrightSpring Health Services’s revenue was up 29.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.11 earnings per share. On average, sell-side analysts anticipate that BrightSpring Health Services will post 0.59 earnings per share for the current year.

Insider Activity at BrightSpring Health Services

In related news, CFO Jennifer A. Phipps sold 35,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total transaction of $1,440,250.00. Following the sale, the chief financial officer directly owned 196,840 shares of the company’s stock, valued at $8,099,966. This represents a 15.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Lisa A. Nalley sold 30,000 shares of the stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total transaction of $1,234,500.00. Following the sale, the insider owned 110,594 shares in the company, valued at approximately $4,550,943.10. This trade represents a 21.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 285,000 shares of company stock worth $11,727,750. Corporate insiders own 3.40% of the company’s stock.

Institutional Trading of BrightSpring Health Services

A number of large investors have recently modified their holdings of BTSG. Lisanti Capital Growth LLC purchased a new stake in BrightSpring Health Services during the 3rd quarter worth about $1,959,000. Federated Hermes Inc. raised its position in BrightSpring Health Services by 44.8% in the 3rd quarter. Federated Hermes Inc. now owns 319,200 shares of the company’s stock valued at $9,436,000 after purchasing an additional 98,745 shares in the last quarter. Prescott Group Capital Management L.L.C. purchased a new position in shares of BrightSpring Health Services in the 3rd quarter valued at about $887,000. Ellsworth Advisors LLC purchased a new position in shares of BrightSpring Health Services in the 3rd quarter valued at about $983,000. Finally, Bailard Inc. acquired a new position in shares of BrightSpring Health Services during the third quarter worth about $378,000.

Key Stories Impacting BrightSpring Health Services

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Regulatory progress on the Community Living divestiture reduces a major overhang and supports the timeline for closing and expected leverage reduction; this helped lift sentiment and is cited as a catalyst for the rally. BrightSpring Health (BTSG) jumps 7.8% as investors refocus on divestiture progress and balance-sheet catalysts
• Positive Sentiment: Strong Q4 performance in BrightSpring’s Senior Health, Home Health & Hospice group — revenue and segment strength beat expectations and reinforce the company’s growth and margin outlook for investors. BrightSpring Health Services (NASDAQ:BTSG): Strongest Q4 Results from the Senior Health, Home Health & Hospice Group
• Positive Sentiment: Analyst optimism and price-target increases — UBS raised its target to $55 (Buy) and Mizuho to $52 (Outperform), adding institutional validation and upside vs. the current price. Broad analyst buy-side coverage supports the bullish case. Benzinga coverage of analyst price target raises
• Neutral Sentiment: Analyst/Investor Day transcript released — management provided detailed updates on strategy, divestiture progress and capital allocation; useful for modeling but much of the news appears to be getting priced in. BrightSpring Health Services, Inc. (BTSG) Analyst/Investor Day Transcript
• Neutral Sentiment: Technical/momentum signals — Zacks flagged a recent >7% move on above‑average volume and highlighted positive estimate revisions; these can amplify moves but aren’t guarantees of continuation. BTSG Moves 7.8% Higher: Will This Strength Last?
• Negative Sentiment: Insider and large-shareholder selling — significant sales by KKR-related entities and other insiders (and a large secondary offering earlier this month) present potential supply pressure despite the company’s concurrent buyback. BrightSpring Health (BTSG) jumps 7.8%… (insider activity)
• Negative Sentiment: FTC clearance is conditional — the Sevita deal progress is positive, but required facility divestitures and related conditions could alter deal economics or timing, posing execution risk until closing. BrightSpring Health (BTSG) jumps 7.8%… (FTC conditions)

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.